HUMA- Humacyte, Inc.

Name: Humacyte, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Humacyte, Inc. (HUMA) has 14 insiders with recent SEC Form 4 filings, including 5 buys and 15 sells. HUMA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Parikh Shamik J	318.6K	$360.0K	-
CFO	Sander Dale A.	313.1K	$353.8K	-
Dir	Dougan Brady W	311.1K	$351.5K	-
CEO	Niklason Laura E	311.1K	$351.5K	-
Dir	Windham-Bannister Susan Richards	80.0K	$90.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 27, 2024	Sander Dale A.58	CFO And Chief Corp. Deve. Off.	Sale+OE	39,389	$6.68	$263,118.52	-95.2%	-35.7%	-77.0%
Aug 15, 2024	Constantino Michael T.	Director	Buy	3,100	$6.29	$19,493.73	+33.5%	-13.0%	-69.4%
Jun 12, 2024	Niklason Laura E66	President, CEO And Director	Sell	630,148	$7.17	$4,520,024.40	-4.2%	-28.5%	-67.2%
Jun 12, 2024	Dougan Brady W60	Director	Sell	630,148	$7.17	$4,520,024.40	-4.2%	-28.5%	-67.2%
Jun 4, 2024	Niklason Laura E66	President, CEO And Director	Buy	2,362	$6.35	$14,998.70	+1.0%	-17.0%	-60.6%
Jun 4, 2024	Dougan Brady W60	Director	Buy	2,362	$6.35	$14,998.70	+1.0%	-17.0%	-60.6%
Jun 4, 2024	Dougan Brady W60	Director	Sell	1,001,852	$7.82	$7,832,200.47	-4.5%	-17.0%	-60.6%
Jun 4, 2024	Niklason Laura E66	President, CEO And Director	Sell	1,001,852	$7.82	$7,832,200.47	-4.5%	-17.0%	-60.6%
Jun 3, 2024	Dougan Brady W60	Director	Buy	2,050	$7.37	$15,108.50	+0.9%	-24.9%	-64.6%
Jun 3, 2024	Niklason Laura E66	President, CEO And Director	Buy	2,050	$7.37	$15,108.50	+0.9%	-24.9%	-64.6%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC